Aytu BioPharma (AYTU) Competitors $2.02 -0.01 (-0.49%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$2.02 0.00 (0.00%) As of 09:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AYTU vs. MRNS, INKT, ALLK, SCLX, CALC, GRCE, SRZN, OKUR, GBIO, and CVKDShould you be buying Aytu BioPharma stock or one of its competitors? The main competitors of Aytu BioPharma include Marinus Pharmaceuticals (MRNS), MiNK Therapeutics (INKT), Allakos (ALLK), Scilex (SCLX), CalciMedica (CALC), Grace Therapeutics (GRCE), Surrozen (SRZN), OnKure Therapeutics (OKUR), Generation Bio (GBIO), and Cadrenal Therapeutics (CVKD). These companies are all part of the "pharmaceutical products" industry. Aytu BioPharma vs. Marinus Pharmaceuticals MiNK Therapeutics Allakos Scilex CalciMedica Grace Therapeutics Surrozen OnKure Therapeutics Generation Bio Cadrenal Therapeutics Marinus Pharmaceuticals (NASDAQ:MRNS) and Aytu BioPharma (NASDAQ:AYTU) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking, media sentiment and dividends. Does the media refer more to MRNS or AYTU? In the previous week, Aytu BioPharma had 1 more articles in the media than Marinus Pharmaceuticals. MarketBeat recorded 4 mentions for Aytu BioPharma and 3 mentions for Marinus Pharmaceuticals. Aytu BioPharma's average media sentiment score of 0.97 beat Marinus Pharmaceuticals' score of 0.00 indicating that Aytu BioPharma is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Marinus Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aytu BioPharma 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend MRNS or AYTU? Marinus Pharmaceuticals presently has a consensus target price of $4.79, indicating a potential upside of 771.56%. Given Marinus Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Marinus Pharmaceuticals is more favorable than Aytu BioPharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Marinus Pharmaceuticals 0 Sell rating(s) 7 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.40Aytu BioPharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is MRNS or AYTU more profitable? Aytu BioPharma has a net margin of -7.62% compared to Marinus Pharmaceuticals' net margin of -446.48%. Aytu BioPharma's return on equity of -19.30% beat Marinus Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Marinus Pharmaceuticals-446.48% -7,831.35% -120.74% Aytu BioPharma -7.62%-19.30%-4.80% Which has more volatility and risk, MRNS or AYTU? Marinus Pharmaceuticals has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500. Comparatively, Aytu BioPharma has a beta of -0.1, suggesting that its stock price is 110% less volatile than the S&P 500. Do insiders and institutionals hold more shares of MRNS or AYTU? 98.8% of Marinus Pharmaceuticals shares are held by institutional investors. Comparatively, 33.5% of Aytu BioPharma shares are held by institutional investors. 5.5% of Marinus Pharmaceuticals shares are held by insiders. Comparatively, 3.6% of Aytu BioPharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, MRNS or AYTU? Aytu BioPharma has higher revenue and earnings than Marinus Pharmaceuticals. Aytu BioPharma is trading at a lower price-to-earnings ratio than Marinus Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarinus Pharmaceuticals$30.99M0.98-$141.40M-$2.47-0.22Aytu BioPharma$77.23M0.16-$15.84M-$0.72-2.81 Does the MarketBeat Community prefer MRNS or AYTU? Marinus Pharmaceuticals received 182 more outperform votes than Aytu BioPharma when rated by MarketBeat users. However, 67.11% of users gave Aytu BioPharma an outperform vote while only 65.42% of users gave Marinus Pharmaceuticals an outperform vote. CompanyUnderperformOutperformMarinus PharmaceuticalsOutperform Votes43765.42% Underperform Votes23134.58% Aytu BioPharmaOutperform Votes25567.11% Underperform Votes12532.89% SummaryMarinus Pharmaceuticals beats Aytu BioPharma on 10 of the 19 factors compared between the two stocks. Get Aytu BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AYTU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AYTU vs. The Competition Export to ExcelMetricAytu BioPharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.46M$6.49B$5.35B$8.38BDividend YieldN/A2.66%5.22%4.10%P/E Ratio-1.398.9226.8419.71Price / Sales0.16253.79392.34117.39Price / CashN/A65.8538.2534.62Price / Book0.446.466.794.50Net Income-$15.84M$143.98M$3.23B$248.18M7 Day Performance49.63%3.04%4.07%1.14%1 Month Performance96.12%7.44%12.52%15.20%1 Year Performance-35.67%-2.46%16.83%6.56% Aytu BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AYTUAytu BioPharma1.8205 of 5 stars$2.02-0.5%N/A-35.7%$12.46M$77.23M-1.39160MRNSMarinus Pharmaceuticals1.8693 of 5 stars$0.55-0.2%$4.79+771.6%-58.7%$30.32M$30.99M-0.22110News CoverageAnalyst ForecastINKTMiNK Therapeutics2.6061 of 5 stars$7.60+8.1%$37.50+393.4%-22.2%$30.14MN/A-1.9530Earnings ReportAnalyst RevisionGap UpALLKAllakos4.2132 of 5 stars$0.33+0.3%$2.00+506.8%N/A$29.79MN/A-0.16190SCLXScilex1.547 of 5 stars$4.10+2.2%$455.00+10,997.6%-87.8%$28.50M$56.59M-4.9480High Trading VolumeCALCCalciMedica2.5765 of 5 stars$2.01+0.5%$18.00+795.5%-67.6%$28.08MN/A-1.8630GRCEGrace Therapeutics1.8472 of 5 stars$2.72flat$12.00+341.2%N/A$27.58MN/A-2.34N/APositive NewsSRZNSurrozen2.9896 of 5 stars$8.00-4.2%$38.50+381.3%-24.7%$26.25M$10.66M-0.3280Gap DownOKUROnKure Therapeutics2.9271 of 5 stars$1.95+1.6%$32.33+1,558.1%N/A$26.20MN/A-0.16N/AInsider TradeGap DownGBIOGeneration Bio3.272 of 5 stars$0.39+8.4%$7.33+1,778.4%-88.4%$26.16M$19.89M-0.18150Negative NewsHigh Trading VolumeCVKDCadrenal Therapeutics2.5318 of 5 stars$13.38-7.4%$32.00+139.2%N/A$25.96MN/A-2.004 Related Companies and Tools Related Companies Marinus Pharmaceuticals Alternatives MiNK Therapeutics Alternatives Allakos Alternatives Scilex Alternatives CalciMedica Alternatives Grace Therapeutics Alternatives Surrozen Alternatives OnKure Therapeutics Alternatives Generation Bio Alternatives Cadrenal Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AYTU) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aytu BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aytu BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AYTU Stock Free AYTU Stock Alerts